Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences
- National Institute on Drug Abuse
This publication has 30 references indexed in Scilit:
- Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV)Neuropharmacology, 2014
- Baths Salts, Spice, and Related Designer Drugs: The Science Behind the HeadlinesJournal of Neuroscience, 2014
- R. C. Baselt (ed.): Disposition of toxic drugs and chemicals in man, 10th editionForensic Science, Medicine and Pathology, 2014
- The analytical investigation of synthetic street drugs containing cathinone analogsForensic Science International, 2014
- Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for foodVaccine, 2013
- Pharmacological characterization of designer cathinonesin vitroBritish Journal of Pharmacology, 2012
- Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in ratsVaccine, 2012
- Synthesis of Mercapto-(+)-methamphetamine Haptens and Their Use for Obtaining Improved Epitope Density on (+)-Methamphetamine Conjugate VaccinesJournal of Medicinal Chemistry, 2011
- Using Hapten Design to Discover Therapeutic Monoclonal Antibodies for Treating Methamphetamine AbuseThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Efficacy of a therapeutic cocaine vaccine in rodent modelsNature Medicine, 1996